| RS587776488 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS587776492 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS587776497 |
ECHS1
|
Health Risk |
Pathogenic |
Leigh syndrome, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |
| RS587776498 |
ECHS1
|
Health Risk |
Pathogenic |
Leigh syndrome, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |
| RS587776507 |
ACKR1
|
Health Risk |
Pathogenic |
DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE |
| RS587776508 |
MTRFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 7, Abnormal brain morphology |
| RS587776509 |
CANT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 1, Desbuquois dysplasia 1 |
| RS587776510 |
CANT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 1, Desbuquois dysplasia 1 |
| RS587776512 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS587776513 |
TACO1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS587776514 |
RFX6
|
Health Risk |
Pathogenic |
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome, Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome |
| RS587776515 |
RFX6
|
Health Risk |
Pathogenic |
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome, Diabetes mellitus |
| RS587776516 |
RFX6
|
Health Risk |
Pathogenic |
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome, Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome |
| RS587776517 |
RFX6
|
Health Risk |
Pathogenic |
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome, Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome |
| RS587776518 |
FBN2
|
Health Risk |
Likely pathogenic |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS587776519 |
FBN2
|
Health Risk |
Pathogenic |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS587776520 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial multiple polyposis syndrome |
| RS587776521 |
SRD5A3
|
Health Risk |
Pathogenic |
SRD5A3-congenital disorder of glycosylation, Kahrizi syndrome |
| RS587776522 |
MIR96
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 50, Autosomal dominant nonsyndromic hearing loss 50 |
| RS587776523 |
MIR96
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 50, Autosomal dominant nonsyndromic hearing loss 50 |
| RS587776524 |
GLB1
|
Health Risk |
Pathogenic |
Infantile GM1 gangliosidosis, Infantile GM1 gangliosidosis |
| RS587776525 |
GLB1
|
Health Risk |
Pathogenic |
Infantile GM1 gangliosidosis, Mucopolysaccharidosis |
| RS587776526 |
GLB1
|
Health Risk |
Pathogenic |
GM1-gangliosidosis, type I |
| RS587776527 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancreatic cancer, susceptibility to |
| RS587776531 |
MPLKIP
|
Health Risk |
Pathogenic |
Trichothiodystrophy 4, nonphotosensitive |
| RS587776532 |
MPLKIP
|
Health Risk |
Pathogenic |
Trichothiodystrophy 4, nonphotosensitive |
| RS587776533 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS587776534 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS587776535 |
FIGLA
|
Health Risk |
Pathogenic |
Premature ovarian failure 6, Premature ovarian failure 6 |
| RS587776536 |
SETX
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS587776537 |
SETX
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS587776538 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS587776539 |
ARG1
|
Health Risk |
Likely pathogenic |
Arginase deficiency, Arginase deficiency |
| RS587776540 |
EXT1
|
Health Risk |
Pathogenic |
Chondrosarcoma, Chondrosarcoma |
| RS587776541 |
SOX9
|
Health Risk |
Pathogenic |
CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL, Camptomelic dysplasia |
| RS587776542 |
NHLRC1
|
Health Risk |
Pathogenic |
Myoclonic epilepsy of Lafora 2, Lafora disease |
| RS587776543 |
NHLRC1
|
Health Risk |
Pathogenic |
Myoclonic epilepsy of Lafora 2, Myoclonic epilepsy of Lafora 2 |
| RS587776544 |
SIL1
|
Health Risk |
Pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS587776546 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1G, Usher syndrome type 1 |
| RS587776547 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
T-cell prolymphocytic leukemia, Hereditary cancer-predisposing syndrome |
| RS587776549 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS587776550 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS587776551 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS587776552 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS587776553 |
EPM2A
|
Health Risk |
Pathogenic |
Myoclonic epilepsy of Lafora 1, Lafora disease |
| RS587776554 |
EPM2A
|
Health Risk |
Likely pathogenic |
Myoclonic epilepsy of Lafora 1, Lafora disease |
| RS587776557 |
CDC73
|
Health Risk |
Pathogenic |
Cystic parathyroid adenoma, Cystic parathyroid adenoma |
| RS587776558 |
CDC73
|
Health Risk |
Pathogenic |
Hyperparathyroidism 1, Parathyroid adenoma |
| RS587776559 |
CDC73
|
Health Risk |
Likely pathogenic |
Hyperparathyroidism 2 with jaw tumors, Hereditary cancer-predisposing syndrome |
| RS587776560 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS587776561 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS587776562 |
NF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 2 |
| RS587776563 |
NF2
|
Health Risk |
Pathogenic |
Meningioma, Meningioma |
| RS587776564 |
NF2
|
Health Risk |
Pathogenic |
SMARCB1-related schwannomatosis, SMARCB1-related schwannomatosis |
| RS587776565 |
NF2
|
Health Risk |
Pathogenic |
SMARCB1-related schwannomatosis, SMARCB1-related schwannomatosis |
| RS587776566 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS587776567 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS587776568 |
EVC2
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Curry-Hall syndrome |
| RS587776569 |
IRF6
|
Health Risk |
Pathogenic |
Van der Woude syndrome 1, Van der Woude syndrome 1 |
| RS587776570 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS587776571 |
PAX6
|
Health Risk |
Pathogenic |
Autosomal dominant keratitis, Autosomal dominant keratitis |
| RS587776572 |
PAX6
|
Health Risk |
Likely pathogenic |
Foveal hypoplasia 1, Foveal hypoplasia 1 |
| RS587776573 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS587776574 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS587776575 |
WT1
|
Health Risk |
Pathogenic |
Frasier syndrome, Frasier syndrome |
| RS587776576 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS587776577 |
WT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Frasier syndrome, Nephrotic syndrome |
| RS587776578 |
SUFU
|
Health Risk |
Pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS587776579 |
SUFU
|
Health Risk |
Pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS587776580 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS587776581 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS587776582 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome |
| RS587776583 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, TCOF1-related disorder |
| RS587776584 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS587776585 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS587776586 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS587776587 |
ENAM
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta - hypoplastic autosomal dominant - local, Amelogenesis imperfecta - hypoplastic autosomal dominant - local |
| RS587776588 |
ENAM
|
Health Risk |
Pathogenic/Likely pathogenic |
Amelogenesis imperfecta type 1C, Amelogenesis imperfecta - hypoplastic autosomal dominant - local |
| RS587776589 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS587776590 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 11, Retinal dystrophy |
| RS587776591 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS587776592 |
ITCH
|
Health Risk |
Pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS587776593 |
APTX
|
Health Risk |
Pathogenic |
Ataxia, early-onset |
| RS587776594 |
APTX
|
Health Risk |
Pathogenic |
Ataxia, early-onset |
| RS587776595 |
MFRP
|
Health Risk |
Pathogenic |
Nanophthalmos 2, Isolated microphthalmia 5 |
| RS587776596 |
MFRP
|
Health Risk |
Pathogenic |
Nanophthalmos 2, Isolated microphthalmia 5 |
| RS587776597 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS587776599 |
SLC2A10
|
Health Risk |
Pathogenic |
Arterial tortuosity syndrome, Arterial tortuosity syndrome |
| RS587776600 |
SLC2A10
|
Health Risk |
Pathogenic |
Arterial tortuosity syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS587776601 |
SLURP1
|
Health Risk |
Pathogenic |
Acroerythrokeratoderma, Acroerythrokeratoderma |
| RS587776602 |
SLURP1
|
Health Risk |
Pathogenic |
Acroerythrokeratoderma, Acroerythrokeratoderma |
| RS587776603 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS587776604 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS587776605 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS587776606 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS587776607 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS587776608 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS587776609 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS587776611 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS587776612 |
ZEB2
|
Health Risk |
Likely pathogenic |
— |